Comparative efficacy and safety of nivolumab vs. docetaxel as second-line treatment in advanced non-small cell lung cancer: A systematic review and meta-analysis.
Authors: Abdul Moeez, Aizaz Ali, Osama Ahmad, Muhammad Ahmad, Zaryab Bacha, Umama Alam, Abdullah Afridi